CClinicalTrials.gg
CompletedNCT03403192Updated Oct 7, 2021Results posted

EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery

An interventional study of EZ-Blocker and DLT in Thoracic Injuries, sponsored by Wake Forest University Health Sciences. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-10-07.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
163
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery.

An additional objective will be to assess time to placement of both devices and other significant clinical differences between these two approaches to placement of the bronchial blocker (BB) including airway injury and post-operatives sore throat, post-operative hoarseness, Additionally we would like to examine the preoperative high resolution CT imaging data to determine if there are anatomic landmarks that may potentially inform the appropriateness or inappropriateness of choosing an EZ-blocker or left sided DLT.

Read the detailed description

One lung ventilation (OLV) is frequently used in thoracic surgery to promote surgical exposure and improve operative conditions. At this time, there are two different approaches to OLV in routine use in adult thoracic surgery. One approach is to use of a double lumen tube (DLT). The other approach is to use a bronchial blocker (BB). Currently there are several different types of bronchial BBs on the market.

The EZ-Blocker essentially functions as a bronchial blocker with a 7-Fr shaft with two separate occlusive balloons coming off this shaft in a "Y" configuration designed to rest on the carina. Once anchored in place the operator can choose to inflate one of the two occlusive balloons to isolate one main stem bronchus or the other.

A number of studies have been performed comparing BBs to DLTs looking at time and ease of placement, differences in quality of lung isolation, and incidence of sore throat, hoarseness, and other morbidity associated with placement. A recent meta-analysis published by Clayton-Smith et al found that BBs are associated with fewer airway injuries when compared to DLTs. They found the quality of isolation to be equivalent between BBs and DLTs. While quality of isolation over all may be comparable, it has been demonstrated in several studies that positional stability of bronchial blockers such as the Arndt or Cohen, is frequently inferior to that of a DLT.

At this time, there are a small number of trials looking at the use of the EZ-blocker in adult patients. In one study published in 2013 the EZ-blocker was compared to the Cohen Flex-Tip blocker. In this study they found that time to place the EZ-blocker was in fact shorter and that overall the number of repositioning required was less with the EZ-blocker. In 2013, a study was published by Mourisse et al which compared DLT to the EZ-blocker. In this study they found initial malposition of both devices to be fairly equivalent, and time to placement was longer with the EZ-blocker. They also found more tracheal and bronchial injuries in the DLT group, but importantly they found that positional stability was equivalent. In both of these studies however they did not design their studies to effectively differentiate between right and left sided procedures when quantifying the need for BB repositioning. Because the takeoff of the right upper lobe bronchus is sometimes adjacent to, or proximal to the carina, it can impede effective isolation with a BB. Therefore, claims of positional stability may rely heavily on the laterality of the procedure, with right sided isolation being significantly more labile than left sided especially with respect to isolation using a BB.

According to the manufactures recommendations the EZ-blocker is placed through a Y-piece adaptor included with the blocker kit. A flexible fiberoptic bronchoscope (FFB) is placed in a separate limb of this Y-piece and this fed through alongside the EZ-blocker to visualize and confirm placement of the BB. The balloon is then inflated typically under direct vision to occlude that bronchus thus isolating that lung hopefully achieving full lung isolation.

In conclusion then, the study team feels that the potential morbidity of a DLT in terms of the potential for airway injury when compared to a BB suggests that further exploration of the possibility of equivalent positional stability between these devices is necessary. The team also feels that it is necessary to delineate the impact of laterality on the effectiveness of one technique for isolation versus the other.

In addition to this if there is a difference in stability in cases where right sided isolation via the EZ-blocker fails in the setting of multiple repositions or out and out failure the team would like to examine the preoperative high resolution CT data to determine if there are anatomic measurement which could potentially inform the appropriateness or inappropriateness of choosing a DLT over an EZ-blocker.

02

Conditions studied

  • Thoracic Injuries

Browse trials for

Keywords

  • EZ Blocker
  • DLT
  • Double Lumen Tube
  • Thoracic Surgery
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients greater than 18 and 80 years of age scheduled for thoracoscopic surgery or thoracotomy requiring lung isolation
  • Patient presenting as an outpatient for elective thoracic surgery
  • In patients scheduled for thoracic surgery.

Exclusion criteria

Exclusion Criteria:

  • History of difficult airway/intubation
  • Patients suspected to have a difficult airway.
  • Morbid obesity BMI >39
  • Pregnancy
  • Emergency status of surgery
  • Thoracic surgery requiring a right sided double lumen tube
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
163 participants (actual)

Study arms

  • Active comparator
    EZ-Blocker in the left lung

    This arm will receive the EZ-Blocker in the left lung of their body, which functions as a bronchial blocker.

    Device: EZ-Blocker

  • Active comparator
    EZ-Blocker in right lung

    This arm will receive the EZ-Blocker in the right lung of their body, which functions as a bronchial blocker.

    Device: EZ-Blocker

  • Active comparator
    DLT in left lung

    This arm will receive the DLT in the left lung of their body, which functions as a bronchial blocker.

    Device: DLT

  • Active comparator
    DLT in right lung

    This arm will receive the DLT in the right lung of their body, which functions as a bronchial blocker.

    Device: DLT

Interventions

  • DeviceEZ-Blocker

    The EZ-Blocker essentially functions as a bronchial blocker with a 7-Fr shaft with two separate occlusive balloons coming off this shaft in a "Y" configuration designed to rest on the carina. Once anchored in place the operator can choose to inflate one of the two occlusive balloons to isolate one main stem bronchus or the other. According to the manufactures recommendations the EZ-blocker is placed through a Y-piece adaptor included with the blocker kit. A flexible fiberoptic bronchoscope (FFB) is placed in a separate limb of this Y-piece and this fed through along side the EZ-blocker to visualize and confirm placement of the of the BB. The balloon is then inflated typically under direct vision to occlude that bronchus thus isolating that lung hopefully achieving full lung isolation.

  • DeviceDLT

    A Double Lumen Tube (DLT) is made of two small-lumen endotracheal tubes of unequal length fixed side by side. The shorter tube ends in the trachea while the longer tube is placed in either the right or left bronchus to ventilate the right or left lung.

05

What researchers measure

Primary outcomes

  1. Number of Double Lumen Tube (DLT) or Bronchial Blocker (BB) Replacements

    Positional stability of lung isolation by measuring number of replacements due to device moving too deep or too shallow (proximal) within the lung.

    Time frame: End of surgical procedure

Secondary outcomes

  1. Time it Takes to Place for Double Lumen Tube (DLT) and EZ

    Time of placement for both devices

    Time frame: End of surgical procedure

  2. Quality of Lung Isolation Between Devices

    Measured at 1 hour intervals during operation on a scale of 1-3 with 1 being Excellent, 2 being Fair, and 3 being Poor.

    Time frame: End of surgical procedure

  3. Side Effects of Devices

    Sore throat/hoarseness postoperatively on a scale of 0-100 with 0 being No Sore Throat and 100 being Worst Sore Throat Imaginable.

    Time frame: 2 days post operation

06

Results

Posted Oct 7, 2021

Participant flow

Participant flow — Overall Study
MilestoneEZ-Blocker in the Left LungEZ-Blocker in Right LungDLT in Left LungDLT in Right Lung
Started41404042
Completed37363736
Not completed4436
Withdrew: Lost to follow-up1200
Withdrew: Unable to respond0100
Withdrew: Incomplete3136

Outcome measures

PrimaryNumber of Double Lumen Tube (DLT) or Bronchial Blocker (BB) Replacements

Positional stability of lung isolation by measuring number of replacements due to device moving too deep or too shallow (proximal) within the lung.

Time frame:
End of surgical procedure
Reported as:
Number · Number of replacements
Number of Double Lumen Tube (DLT) or Bronchial Blocker (BB) Replacements
Number of replacementsEZ-Blocker in the Left LungEZ-Blocker in Right LungDLT in Left LungDLT in Right Lung
Number of Double Lumen Tube (DLT) or Bronchial Blocker (BB) Replacements13141413
SecondaryTime it Takes to Place for Double Lumen Tube (DLT) and EZ

Time of placement for both devices

Time frame:
End of surgical procedure
Reported as:
Median · Minutes
Time it Takes to Place for Double Lumen Tube (DLT) and EZ
MinutesEZ-Blocker in the Left LungEZ-Blocker in Right LungDLT in Left LungDLT in Right Lung
Time it Takes to Place for Double Lumen Tube (DLT) and EZ3.2 (2.7 to 4.5)3.3 (2.5 to 4.9)2.0 (1.5 to 3.9)2.6 (1.3 to 3.8)
SecondaryQuality of Lung Isolation Between Devices

Measured at 1 hour intervals during operation on a scale of 1-3 with 1 being Excellent, 2 being Fair, and 3 being Poor.

Time frame:
End of surgical procedure
Reported as:
Mean · score on a scale
Quality of Lung Isolation Between Devices
score on a scaleEZ-Blocker in the Left LungEZ-Blocker in Right LungDLT in Left LungDLT in Right Lung
Quality of Lung Isolation Between Devices2.76 ± 0.392.70 ± 0.482.92 ± 0.262.83 ± 0.37
SecondarySide Effects of Devices

Sore throat/hoarseness postoperatively on a scale of 0-100 with 0 being No Sore Throat and 100 being Worst Sore Throat Imaginable.

Time frame:
2 days post operation
Reported as:
Median · score on a scale
Side Effects of Devices
score on a scaleEZ-Blocker in the Left LungEZ-Blocker in Right LungDLT in Left LungDLT in Right Lung
Side Effects of Devices0 (0 to 5)3 (0 to 13)5 (0 to 12)0 (0 to 7)

Adverse events

Collected over 48 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
EZ-Blocker in the Left Lung0/41 (0%)0/41 (0%)0/41 (0%)
EZ-Blocker in Right Lung0/40 (0%)0/40 (0%)0/40 (0%)
DLT in Left Lung0/40 (0%)0/40 (0%)0/40 (0%)
DLT in Right Lung0/42 (0%)0/42 (0%)0/42 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
Mean62.1 ± 10.565.3 ± 12.466.2 ± 12.960.6 ± 11.763.5 ± 12.02
Sex: Female, Male
Sex: Female, Male(Participants)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
Female2019152276
Male2121252087
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
Count of participants————0
Region of Enrollment
Region of Enrollment(Participants)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
United States41404042163
Weight
Weight(kilograms)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
Mean81.0 ± 17.177.0 ± 17.782.9 ± 16.482.0 ± 20.080.7 ± 17.8
Body Mass Index (BMI)
Body Mass Index (BMI)(kg/m^2)EZ-Blocker in the Left LungEZ-Blocker in Right LungDouble Lumen Tube (DLT) in Left LungDouble Lumen Tube (DLT) in Right LungTotal
Mean27.8 ± 4.826.5 ± 5.028.3 ± 4.7928.5 ± 5.627.8 ± 5.1
07

Study locations

1 site
  • Wake Forest Baptist Hospital
    Winston-Salem, North Carolina 27157, United States
08

References and documents

Publications

  • Mungroop HE, Wai PT, Morei MN, Loef BG, Epema AH. Lung isolation with a new Y-shaped endobronchial blocking device, the EZ-Blocker. Br J Anaesth. 2010 Jan;104(1):119-20. doi: 10.1093/bja/aep353. No abstract available. PubMed 20007802 ↗
  • Dumans-Nizard V, Liu N, Laloe PA, Fischler M. A comparison of the deflecting-tip bronchial blocker with a wire-guided blocker or left-sided double-lumen tube. J Cardiothorac Vasc Anesth. 2009 Aug;23(4):501-5. doi: 10.1053/j.jvca.2009.02.002. Epub 2009 Apr 10. PubMed 19362014 ↗
  • Campos JH, Hallam EA, Van Natta T, Kernstine KH. Devices for lung isolation used by anesthesiologists with limited thoracic experience: comparison of double-lumen endotracheal tube, Univent torque control blocker, and Arndt wire-guided endobronchial blocker. Anesthesiology. 2006 Feb;104(2):261-6, discussion 5A. doi: 10.1097/00000542-200602000-00010. PubMed 16436844 ↗
  • Knoll H, Ziegeler S, Schreiber JU, Buchinger H, Bialas P, Semyonov K, Graeter T, Mencke T. Airway injuries after one-lung ventilation: a comparison between double-lumen tube and endobronchial blocker: a randomized, prospective, controlled trial. Anesthesiology. 2006 Sep;105(3):471-7. doi: 10.1097/00000542-200609000-00009. PubMed 16931978 ↗
  • Clayton-Smith A, Bennett K, Alston RP, Adams G, Brown G, Hawthorne T, Hu M, Sinclair A, Tan J. A Comparison of the Efficacy and Adverse Effects of Double-Lumen Endobronchial Tubes and Bronchial Blockers in Thoracic Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth. 2015 Aug;29(4):955-66. doi: 10.1053/j.jvca.2014.11.017. Epub 2014 Dec 2. PubMed 25753765 ↗
  • Kus A, Hosten T, Gurkan Y, Gul Akgul A, Solak M, Toker K. A comparison of the EZ-Blocker with a Cohen Flex-Tip blocker for one-lung ventilation. J Cardiothorac Vasc Anesth. 2014 Aug;28(4):896-9. doi: 10.1053/j.jvca.2013.02.006. Epub 2013 Aug 16. PubMed 23958073 ↗
  • Mourisse J, Liesveld J, Verhagen A, van Rooij G, van der Heide S, Schuurbiers-Siebers O, Van der Heijden E. Efficiency, efficacy, and safety of EZ-blocker compared with left-sided double-lumen tube for one-lung ventilation. Anesthesiology. 2013 Mar;118(3):550-61. doi: 10.1097/ALN.0b013e3182834f2d. PubMed 23299364 ↗
  • Piccioni F, Vecchi I, Spinelli E, Previtali P, Langer M. Extraluminal EZ-blocker Placement for One-lung Ventilation in Pediatric Thoracic Surgery. J Cardiothorac Vasc Anesth. 2015 Dec;29(6):e71-3. doi: 10.1053/j.jvca.2015.05.200. Epub 2015 May 27. No abstract available. PubMed 26342270 ↗
  • Templeton TW, Downard MG, Simpson CR, Zeller KA, Templeton LB, Bryan YF. Bending the rules: a novel approach to placement and retrospective experience with the 5 French Arndt endobronchial blocker in children <2 years. Paediatr Anaesth. 2016 May;26(5):512-20. doi: 10.1111/pan.12882. Epub 2016 Mar 9. PubMed 26956889 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 14, 2019
  • Informed consent form · Sep 24, 2019

Documents are hosted by the registry — open the source record to download them.

09

Registry details

Key details

Study ID
NCT03403192
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Jan 18, 2018
Start date
Jan 26, 2018
Primary completion
Oct 29, 2019
Completion
Oct 29, 2019
Results posted
Oct 7, 2021
Last update
Oct 7, 2021

Study contacts

Benjamin N Morris, MD
principal investigator · Assistant Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion